F.D.A. Approves Remdesivir for Patients Not Hospitalized January 22, 2022 Auto Bot BioNTech SE, Coronavirus (2019-nCoV), Coronavirus Omicron Variant, Food and Drug Administration, Pfizer Inc, Remdesivir (Drug) 0 The treatment must be given via intravenous infusion over three consecutive days, generally at a hospital or clinic.